Stock 603367 CISEN PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Cisen Pharmaceutical Co., Ltd.

Equities

603367

CNE100002VG4

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
16.03 CNY +1.20% Intraday chart for Cisen Pharmaceutical Co., Ltd. +5.18% +9.49%
Apr. 23 Cisen Pharmaceutical Names Chief Financial Officer MT
Apr. 22 Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 6,882 7,503 6,229 5,978 5,668 6,601
Enterprise Value (EV) 1 4,717 5,244 4,020 3,698 3,042 3,996
P/E ratio 13.7 x 14.5 x 14.3 x 18 x 16.4 x 12.7 x
Yield 1.73% 1.62% 1.84% 2.25% 2.66% 2.98%
Capitalization / Revenue 1.81 x 1.82 x 1.7 x 1.58 x 1.39 x 1.48 x
EV / Revenue 1.24 x 1.28 x 1.09 x 0.98 x 0.75 x 0.9 x
EV / EBITDA 6.98 x 8.35 x 7.8 x 8.61 x 5.89 x 5.41 x
EV / FCF 13.8 x 2.7 x 11.4 x 27.5 x 10.6 x 9.34 x
FCF Yield 7.23% 37% 8.76% 3.63% 9.43% 10.7%
Price to Book 1.66 x 1.64 x 1.3 x 1.19 x 1.07 x 1.16 x
Nbr of stocks (in thousands) 453,353 453,353 447,799 447,779 449,813 450,871
Reference price 2 15.18 16.55 13.91 13.35 12.60 14.64
Announcement Date 3/20/19 4/28/20 4/8/21 4/26/22 3/30/23 4/22/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 3,808 4,113 3,674 3,783 4,066 4,462
EBITDA 1 675.7 627.8 515.4 429.3 516.4 739.1
EBIT 1 500.6 465.3 357.9 214.2 291.2 512.4
Operating Margin 13.15% 11.31% 9.74% 5.66% 7.16% 11.48%
Earnings before Tax (EBT) 1 568 582.1 484.5 336.1 366.2 595.9
Net income 1 503.5 514.6 438.8 334.1 350.1 521.3
Net margin 13.22% 12.51% 11.94% 8.83% 8.61% 11.68%
EPS 2 1.110 1.140 0.9700 0.7400 0.7700 1.150
Free Cash Flow 1 341.3 1,941 352.1 134.4 287 428
FCF margin 8.96% 47.2% 9.58% 3.55% 7.06% 9.59%
FCF Conversion (EBITDA) 50.5% 309.16% 68.32% 31.3% 55.58% 57.91%
FCF Conversion (Net income) 67.77% 377.21% 80.26% 40.22% 81.98% 82.1%
Dividend per Share 2 0.2620 0.2680 0.2560 0.3000 0.3350 0.4360
Announcement Date 3/20/19 4/28/20 4/8/21 4/26/22 3/30/23 4/22/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 2,165 2,259 2,209 2,280 2,625 2,604
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 341 1,941 352 134 287 428
ROE (net income / shareholders' equity) 12.8% 11.8% 9.33% 6.77% 6.77% 9.45%
ROA (Net income/ Total Assets) 6.26% 5.39% 3.82% 2.14% 2.76% 4.53%
Assets 1 8,040 9,540 11,474 15,634 12,675 11,520
Book Value Per Share 2 9.160 10.10 10.70 11.20 11.80 12.60
Cash Flow per Share 2 0.7600 0.8400 1.480 2.090 2.210 2.170
Capex 1 40.4 103 202 51 35.2 17.7
Capex / Sales 1.06% 2.51% 5.51% 1.35% 0.87% 0.4%
Announcement Date 3/20/19 4/28/20 4/8/21 4/26/22 3/30/23 4/22/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Generic Pharmaceuticals

1st Jan change Capi.
CISEN PHARMACEUTICAL CO., LTD. Stock Cisen Pharmaceutical Co., Ltd.
+9.49% 991M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+19.27% 43.75B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+27.47% 22.06B
SANDOZ GROUP AG Stock Sandoz Group AG
+15.11% 14.46B
CIPLA LIMITED Stock Cipla Limited
+12.33% 13.62B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+38.36% 11.61B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-9.54% 6.9B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+10.21% 5.32B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 603367 Stock
  4. Financials Cisen Pharmaceutical Co., Ltd.